Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

The meteoric rise of the meal kit thanks to a pandemic and a convenience economy

  • In News
  • October 15, 2021
  • Samantha Freidin
The meteoric rise of the meal kit thanks to a pandemic and a convenience economy

The magic of click and collect and home delivered meal kits was around long before COVID-19 however, the pandemic has served as an undeniable accelerator to companies like My Food Bag (ASX:MFB), a New Zealand based meal kit delivery company.

The Company creates and delivers meal kits with 98% NZ ingredients and simple recipe cards inspired by renowned New Zealand based chef, Nadia Lim. The trendy offering is more glamorous than a trip to your local supermarket with all the hard work done for you, minimising food waste and any headache when it comes to planning meals.

Despite lockdowns across the Tasman, the Company has seen largely uninterrupted trading across assembly sites in Auckland and Christchurch. The Company has seen a 3.3% increase in the number of active customers and identified a high value customer cohort, who have purchased at least 20 deliveries in the last 12 months, increasing at a similar rate.

The demand for delivered meal kits saw a marked increase in mid August, coinciding with COVID-19 restrictions and lockdowns once again, coming into play. Other listed meal kit providers experienced this increase as lockdowns legitimised their business models. Hello Fresh gained enough of a stake to start absorbing competitors, the first being YouFoodz (ASX: YFZ) in July of this year which they picked up for $125 million (flexing their muscles whilst doing so, obtaining the Company for a 57% discount on their IPO price).

With a preliminary Net Sales Value of $98.4 million for the 6 months ending September 30, 2021, My Food Bag is on track with earnings. The Board has also affirmed the payment of a dividend in December of this year. The margin improvements come as a result of the rapid adoption of online grocery shopping from macro societal effects of the pandemic.

In a refreshingly transparent statement the Company did indicate that continued growth on their current trajectory will require them to increase the price of selected Bags. The move comes as a strategy to mitigate increasing inflationary pressure around ingredients and labour costs due to supply chain limitations and new operating procedures thanks to COVID-19.

Seems that pandemics can propel certain aspects of the business and stifle others. One thing’s for certain- pandemic or not, having an answer to “what’s for dinner” after a long day at work is priceless.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.